Traditional serum biomarkers, such as C-reactive protein (CRP) and MPO-ANCA, cannot predict the presence and severity of peripheral motor neuropathy and sensory neuropathy in MPA [8]. The gene discussed is CRP; the disease is sensory peripheral neuropathy.